Suppr超能文献

肿瘤切除术后小儿中面部的重建。

Reconstruction of the pediatric midface following oncologic resection.

作者信息

Garfein Evan, Doscher Matthew, Tepper Oren, Gill Jonathan, Gorlick Richard, Smith Richard V

机构信息

Department of Otorhinolaryngology - Head and Neck Surgery, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.

Department of Surgery, Division of Plastic and Reconstructive Surgery, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.

出版信息

J Reconstr Microsurg. 2015 Jun;31(5):336-42. doi: 10.1055/s-0035-1544181. Epub 2015 Mar 24.

Abstract

BACKGROUND

Sarcoma is the most common midface malignancy in children. While first-line treatment in adults is resection, the challenges associated with resection and reconstruction of these tumors in children often lead to radiation therapy as primary treatment. This report highlights the feasibility and efficacy of midface reconstruction in the pediatric population after resection. In most cases, the same principles utilized in reconstructing midface defects in adults hold for the pediatric population.

PATIENTS AND METHODS

From 2008 to 2013 seven pediatric patients underwent resection and reconstruction for maxillary sarcomas. These patients ranged in age from 18 months to 20 years. Five patients were reconstructed with six microvascular free flaps. Two patients received pedicled flaps. Follow-up ranged from 15 months to 4.5 years. Reconstructive, oncological, and functional outcomes were analyzed.

RESULTS

Seven patients underwent eight reconstructions for sarcomas of the maxilla. Flaps utilized included vertical rectus abdominis, anterolateral thigh, fibula, and temporoparietal fascia. One flap was complicated by venous thrombosis but was successfully salvaged after thrombectomy and revision using vein graft. One patient developed recurrence after initial flap placement and required salvage resection and a second free flap. Six patients were judged to have good facial symmetry and tolerated a regular oral diet with normal or near-normal dental occlusion.

CONCLUSIONS

Standard primary therapy for sarcomas of the maxilla in the pediatric population consists of nonsurgical management. However, a radiation-first approach is associated with significant morbidity and makes surgical salvage more difficult. Based on our experience, microsurgical reconstruction of the pediatric midface is safe and effective, and should be considered a first-line treatment option for midface sarcomas in children. In general, there is no significant area of departure between the principles that govern midface reconstruction in adults and children.

摘要

背景

肉瘤是儿童最常见的面中部恶性肿瘤。虽然成人的一线治疗是手术切除,但儿童这些肿瘤的切除和重建相关挑战常导致放疗作为主要治疗方法。本报告强调了儿童群体切除术后面中部重建的可行性和疗效。在大多数情况下,成人面中部缺损重建所采用的相同原则也适用于儿童群体。

患者与方法

2008年至2013年,7例儿童患者因上颌骨肉瘤接受了切除和重建手术。这些患者年龄从18个月至20岁不等。5例患者采用6个游离微血管皮瓣进行重建。2例患者接受带蒂皮瓣。随访时间为15个月至4.5年。对重建、肿瘤学和功能结果进行了分析。

结果

7例患者因上颌骨肉瘤接受了8次重建手术。使用的皮瓣包括腹直肌、股前外侧、腓骨和颞顶筋膜。1个皮瓣出现静脉血栓形成并发症,但在血栓切除术和使用静脉移植物进行修复后成功挽救。1例患者在初次皮瓣植入后出现复发,需要进行挽救性切除和第二次游离皮瓣。6例患者面部对称性良好,能够耐受正常或接近正常牙合的常规口腔饮食。

结论

儿童上颌骨肉瘤的标准初始治疗包括非手术治疗。然而,放疗优先的方法会带来显著的发病率,并使手术挽救更加困难。根据我们的经验,儿童面中部的显微外科重建是安全有效的,应被视为儿童面中部肉瘤的一线治疗选择。一般来说,成人和儿童面中部重建的原则之间没有显著差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验